Lv1
20 积分 2025-11-18 加入
Bispecific and multispecific antibodies in oncology: opportunities and challenges
8小时前
已完结
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial
8小时前
已完结
CD28 co-stimulation: novel insights and applications in cancer immunotherapy
2个月前
已完结
皖公网安备34019202002308
